Case Reports

24-year-old man • prednisone therapy for nephrotic syndrome • diffuse maculopapular rash • pruritis

Author and Disclosure Information

► Prednisone therapy to treat nephrotic syndrome
► Diffuse maculopapular rash
► Pruritis


 

References

THE CASE

A 24-year-old man with no past medical history was referred to a nephrologist for a 5-month history of leg swelling and weight gain. His only medication was furosemide 40 mg/d, prescribed by his primary care physician. His physical examination was unremarkable except for lower extremity and scrotal edema.

Laboratory values included a creatinine of 0.8 mg/dL (reference range, 0.6 to 1.2 mg/dL); hemoglobin concentration, 14.4 g/dL (reference range, 14 to 18 g/dL); albumin, 1.9 g/dL (reference range, 3.5 to 5.5 g/dL); and glucose, 80 mg/dL (reference range, 74 to 106 mg/dL). Electrolyte levels were normal. Urinalysis revealed 3+ blood and 4+ protein on dipstick, as well as the presence of granular and lipid casts on microscopic exam. A 24-hour urine collection contained 10.5 g of protein. Antinuclear antibody titers, complement levels, hepatitis serologies, and antineutrophil cytoplasmic antibody titers were all normal.

A renal biopsy revealed idiopathic focal segmental glomerulosclerosis. The patient was started on oral prednisone 40 mg twice daily.

Two days later, he developed a diffuse pruritic maculopapular rash. He stopped taking the prednisone, and the rash resolved over the next 3 to 5 days. He was then instructed to restart the prednisone for his nephrotic syndrome. When he developed a new but similar rash, the prednisone was discontinued. The rash again resolved.

THE DIAGNOSIS

Since the patient had already been taking furosemide for 6 weeks without an adverse reaction, it was presumed that the prednisone tablet was causing his rash. It would be unusual for prednisone itself to cause a drug eruption, so an additive or coloring agent in the tablet was thought to be responsible for the reaction.

We noted that the patient had been taking a 20-mg orange tablet of prednisone. So we opted to “tweak” the prescription and prescribe the same daily dose but in the form of 10-mg white tablets. The patient tolerated this new regimen without any adverse effects and completed a full 9 months of prednisone therapy without any recurrence of skin lesions. His glomerular disease went into remission.

DISCUSSION

Excipients are inert substances that are added to a food or drug to provide the desired consistency, appearance, or form. They are also used as a preservative for substance stabilization.

Continue to: There are many reports in the literature...

Pages

Recommended Reading

Rapid-onset rash
MDedge Family Medicine
Hyperkalemia most common adverse event in women taking spironolactone
MDedge Family Medicine
COVID-19 complicates prescribing for children with inflammatory skin disease
MDedge Family Medicine
California wildfires caused uptick in clinic visits for atopic dermatitis, itch
MDedge Family Medicine
Cancer risk elevated in hidradenitis suppurativa patients
MDedge Family Medicine
Atopic dermatitis in adults, children linked to neuropsychiatric disorders
MDedge Family Medicine
Today’s top news highlights: COVID-19 could worsen gambling problems, food allergies less common than thought
MDedge Family Medicine
Painful ear lesion
MDedge Family Medicine
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseases
MDedge Family Medicine
Growing scalp nodule
MDedge Family Medicine